DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Penlac (Ciclopirox Topical) - Published Studies

 
 



Penlac Related Published Studies

Well-designed clinical trials related to Penlac (Ciclopirox Topical)

A randomized, double-blind study comparing the efficacy of selenium sulfide shampoo 1% and ciclopirox shampoo 1% as adjunctive treatments for tinea capitis in children. [2010.09]

Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis. [2009.12]

Clinical efficacy of a new ciclopiroxolamine/zinc pyrithione shampoo in scalp seborrheic dermatitis treatment. [2006.09]

Treatment of head and neck dermatitis with ciclopiroxolamine cream--results of a double-blind, placebo-controlled study. [2006]

Ciclopirox topical solution, 8% combined with oral terbinafine to treat onychomycosis: a randomized, evaluator-blinded study. [2005.07]

Evaluation of the efficacy of ciclopirox 0.77% gel in the treatment of tinea pedis interdigitalis (dermatophytosis complex) in a randomized, double-blind, placebo-controlled trial. [2005.07]

Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo. [2005.01]

Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis. [2005]

Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial. [2004.07]

Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage. [2004.07]

Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial. [2004.07]

A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers. [2004]

Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea. [2003.12]

Ciclopirox gel in the treatment of patients with interdigital tinea pedis. [2003.09]

Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis. [2003]

Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison. [2002.12]

Randomized prospective comparative study: short-term treatment with ciclopiroxolamine (cream and solution) versus boric acid in the treatment of otomycosis. [2002.10]

A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis. [2002.06]

[Treatment of therapy refractory verrucae vulgares with a ciclopirox-containing lacquer] [2001.06]

Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis. [2001.05]

Ciclopirox 8% nail lacquer in the treatment of onychomycosis of the toenails in the United States. [2000.11]

[Effectiveness and safety of ciclopirox olamine 1% vaginal cream versus terconazole 0.8% vaginal cream in the treatment of genital candidiasis] [2000.04]

Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses. [1988]

Well-designed clinical trials possibly related to Penlac (Ciclopirox Topical)

Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial. [2009.05]

Can the use of a topical antifungal nail lacquer reduce risk for diabetic foot ulceration? Results from a randomised controlled pilot study. [2005.06]

Anti-inflammatory activity of antifungal preparations. [1997.10]

Simplified experimental human dermatophytosis model. [1992.02]

[Therapy of seborrheic eczema with an antifungal agent with an antiphlogistic effect] [1991]

[A clinical study of cyclopyroxolamine versus clotrimazole in the treatment of mycotic vulvovaginitis] [1990.07]

Effect of fenticonazole spray in cutaneous mycosis: a double-blind clinical trial versus cyclopyroxolamine spray. [1990.01]

Other research related to Penlac (Ciclopirox Topical)

Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation. [2011.07]

The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy. [2011.04]

Ciclopirox: recent nonclinical and clinical data relevant to its use as a topical antimycotic agent. [2010.11.12]

A Randomized, Double-Blind Study Comparing the Efficacy of Selenium Sulfide Shampoo 1% and Ciclopirox Shampoo 1% as Adjunctive Treatments for Tinea Capitis in Children. [2010.08.24]

Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine. [2010.08]

Antifungal activity, experimental infections and nail permeation of an innovative ciclopirox nail lacquer based on a water-soluble biopolymer. [2010.05]

Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study. [2010.02]

A randomized, double-blind study comparing the efficacy of selenium sulfide shampoo 1% and ciclopirox shampoo 1% as adjunctive treatments for tinea capitis in children. [2010]

Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection. [2009.11]

Iontophoretically enhanced ciclopirox delivery into and across human nail plate. [2009.10]

An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. [2009.07]

Double-Blind Clinical Trial for Evaluating the Effectiveness and Tolerability of Ageratina pichinchensis Extract on Patients with Mild to Moderate Onychomycosis. A Comparative Study with Ciclopirox. [2008.10]

Antimicrobial activity of iodoquinol 1%-hydrocortisone acetate 2% gel against ciclopirox and clotrimazole. [2008.10]

Ototoxic effect of topical ciclopirox as an antimycotic preparation. [2008.10]

Double-Blind Clinical Trial for Evaluating the Effectiveness and Tolerability of Ageratina pichinchensis Extract on Patients with Mild to Moderate Onychomycosis. A Comparative Study with Ciclopirox. [2008.07.31]

An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis. [2007.11]

[Mucoadhesive tablets for oral administration of ciclopiroxolamine] [2007.10]

Ciclopirox 8% nail lacquer topical solution for the treatment of onychomycosis in patients with diabetes: a multicenter, open-label study. [2007.05]

Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. [2007]

Rapid treatment of tinea nigra palmaris with ciclopirox olamine gel, 0.77%. [2006.07]

Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis. [2006.01]

Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis. [2005.12]

Ciclopirox nail lacquer 8% for the treatment of onychomycosis: a Canadian perspective. [2005.09]

The safety and efficacy of ciclopirox olamine for the treatment of seborrheic dermatitis. [2005.03]

In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water-soluble nail lacquer. [2005.01]

A multicenter, open-label study to assess the safety and efficacy of ciclopirox topical suspension 0.77% in the treatment of diaper dermatitis due to Candida albicans. [2005.01]

Ciclopirox delivery into the human nail plate. [2004.10]

Ciclopirox (Loprox) gel for superficial fungal infections. [2004.08]

Ciclopirox shampoo for treating seborrheic dermatitis. [2004.06]

Managing simple chronic paronychia and onycholysis with ciclopirox 0.77% and an irritant-avoidance regimen. [2004.01]

Interdigital tinea pedis (dermatophytosis simplex and complex) and treatment with ciclopirox 0.77% gel. [2003.09]

Successful treatment of onychomycosis with ciclopirox nail lacquer: a case report. [2001.08]

A multicenter, open-label study of the efficacy and safety of ciclopirox nail lacquer solution 8% for the treatment of onychomycosis in patients with diabetes. [2001.08]

Ciclopirox nail lacquer: a brush with onychomycosis. [2001.08]

Allergic contact dermatitis from ciclopirox olamine. [2001.05]

The dermatopharmacologic profile of ciclopirox 8% nail lacquer. [2000.11]

Ciclopirox nail lacquer solution 8% in the 21st century. [2000.10]

Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis. [2000.10]

Ciclopirox nail lacquer topical solution 8%. [2000]

[Therapy with ciclopirox lacquer of onychomycoses caused by molds] [1994]

Local tolerance of a new ciclopirox olamine vaginal preparation in rats and rabbits. [1993.10]

Pharmacokinetics of ciclopirox olamine after vaginal application to rabbits and patients. [1993.10]

[Topical therapy of onychomycoses with 8% ciclopirox laquer. An open, non-comparative study] [1993.04.30]

HPLC method for pharmacokinetic studies on ciclopirox olamine in rabbits after intravenous and intravaginal administrations. [1992.05]

A clinical and laboratory study of ciclopirox olamine (8% Batrafen) in the treatment of onychomycosis. [1991.09]

Micro-liquid chromatography method for the determination of ciclopiroxolamine after pre-column derivatization in topical formulations. [1991.08.16]

Efficacy of ciclopiroxolamine 1% cream in onychomycosis and tinea pedis. [1991.01]

Ciclopiroxolamine cream 1%: in vitro and in vivo penetration into the stratum corneum. [1991]

Changes in fungal ultrastructure after short-course ciclopiroxolamine therapy in pityriasis versicolor. [1990.03]

Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis. [1989.05]

[Experience in the treatment of skin mycoses with ciclopirox olamine] [1989]

Hendersonula toruloidea infection: successful response of onychomycosis to nail avulsion and topical ciclopiroxolamine. [1987]

Other possibly related research studies

Evaluating Costs for Onychomycosis Treatments: A Practitioner's Perspective. [2006.01]

Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. [2005.01]

Cutaneous adiaspiromycosis: a distinct dermatologic entity associated with Chrysosporium species. [2004.11]

Management of onychomycosis with topicals. [2004.10]

Tinea capitis favosa in Poland. [2004.06]

Assessing treatment outcomes in toenail onychomycosis clinical trials. [2004]

The use of 40% urea cream in the treatment of moccasin tinea pedis. [2004.05]

[Onychomycosis] [2004.02]

Action mechanisms of modern antifungal agents and resulting problems in the management of onychomycosis. [2003.12]

The use of topical therapies to treat onychomycosis. [2003.07]

Onychomycosis: current treatment options. [2003.04]

Economic analysis of oral and topical therapies for onychomycosis of the toenails and fingernails. [2003.03]

Topical treatments for onychomycosis: a historical perspective. [2003.03]

Treatment of onychomycosis in the diabetic patient population. [2003.03]

Treatment of dermatophyte toenail onychomycosis in the United States. A pharmacoeconomic analysis. [2002.05]

[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy] [2000]

[Tinea capitis and corporis caused by Trichophyton soudanense in an immigrant family from Africa] [1999.05.14]

Onychomycosis due to Microsporum gypseum. [1998.09]

The hydroxypyridones: a class of antimycotics of its own. [1997.11]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017